1,101 posts by 291 firms and lawyers
Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.
Marijuana businesses operate in arguably the strangest legal environment in American commerce. They obtain state licenses. They employ people. They lease buildings, borrow money, buy equipment, enter supply agreements, pay taxes,…
Posted in Federal Agencies, Federal Law Developments, Medical Marijuana, Regulations/Compliance
Justin Goldberg, Kirsten Hart, Kendall Murphy, J. Michael Showalter
Having finally gotten that wish, at least one Mississippi dispensary owner is finding out what “federal rules” really means. Not just lower tax bills and easier banking, but also 1970s-vintage security regulations that were…
A Michigan cannabis grower proved its case. A jury found that the buyer breached its supply agreement and awarded the grower $31.8 million in damages. But the grower still walked away without an enforceable verdict.
A Michigan marijuana grower won a $31.8 million jury verdict for breach of contract… then watched it disappear on appeal. On September 10, 2026, the U.S. Court of Appeals for the 6th Circuit held that federal courts cannot…
The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests…
Every good legal thriller needs a twist, and this one’s a doozy: The DEA — the agency that’s spent over 50 years playing prohibition’s final boss — is now the one arguing marijuana doesn’t belong in Schedule I anymore, while the…
On April 23, 2026, the Department of Justice and the Drug Enforcement Administration issued an order moving medical marijuana subject to a state license from Schedule I to Schedule III of the Controlled Substances Act.
Rescheduling did not just change tax treatment and licensing options for cannabis operators. It also changed the assumptions baked into thousands of existing cannabis contracts.
If you aren’t familiar with marijuana, or you’re not a botanist, you may not know that hemp and marijuana are the same plant. Not similar. Not cousins. , separated by a legal distinction so arbitrary it would be funny if it…
Cannabis law has never been more contradictory. , federal and state governments often regulate identical products under completely different legal frameworks. Hemp and marijuana can produce the same intoxicating effects, yet…
On April 23, 2026, the DOJ and DEA issued a final order rescheduling certain marijuana products from Schedule I to Schedule III of the Controlled Substances Act. The order is subject to litigation, but it remains in effect for…
While the medical marijuana rescheduling order made clear that the Drug Enforcement Agency (“DEA”) would prioritize the review of medical marijuana applications submitted during the first sixty (60) days of the application…
The hearing on the Notice of Proposed Rulemaking for the rescheduling of “marijuana” commenced on June 29, 2026 and will end tomorrow, July 15th. The Government brought two witnesses to the stand on the first day, and then seven…
After years of delays and political wrangling, the federal government’s long-awaited hearing on whether to move marijuana from Schedule I to Schedule III of the Controlled Substances Act is finally underway. On Jun. 29th, the DEA…
The Drug Enforcement Administration is scheduled to hold a historic hearing beginning Monday, June 29, 2026, which could extend Schedule III cannabis rescheduling to adult-use marijuana and reshape the federal regulatory…
On June 29, 2026, the Trump administration’s marijuana rescheduling effort enters a new phase as an administrative hearing, first announced on April 23, 2026, begins before a Drug Enforcement Administration (“DEA”) administrative…
On April 28, 2026, Acting Attorney General Blanche (“AG”) issued a notice of hearing concerning the proposed rule to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”).
Article by: Ivy Perez-Bader, Raza Lawrence, Jana Weltzin, Greg Cowan, and Tom Zuber